Molecules/BELIMUMAB

BELIMUMAB

Molecular Identity

AntibodyApprovedFirst approved 2011

Mechanism of action: Tumor necrosis factor ligand superfamily member 13B inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BEL-114333BEL114333BELIMUMABBELIMUMAB (GENETICAL RECOMBINATION)BENLYSTAGSK-1550188GSK1550188HGS-1006HGS1006LYMPHOSTAT-BLYMPHOSTAT-B BENLYSTA

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BELIMUMAB

Loading drug network...